register

News & Trends - MedTech & Diagnostics

$100 million funding for major advances in medical technology

Health Industry Hub | March 1, 2021 |

MedTech News: $100 million is being invested into the development of new medical technologies to improve diagnosis and treatment of stroke, epilepsy and lung disease, including COVID-19.

The Government funding will be split across three research projects led by senior researchers at the University of Melbourne, the Australian Lung Health Initiative, and Florey Institute of Neuroscience and Mental Health.

The five year funding is being provided under Stage Two of the Frontier Health and Medical Research Initiative, a program which allows researcher collaborations to explore the most bold and exciting ideas that could have a dramatic, global impact on health care.

The successful projects were chosen from 10 applicants, which each received up to $1.5 million in funding to develop ground-breaking ideas into research plans. The research plans were then assessed by an independent committee of Australian and international experts.

The selected projects are:

  1. The Stroke Golden Hour project to develop lightweight brain scanners that can be carried in ambulances. This will allow ambulance officers to provide rapid diagnosis and treatment to stroke victims, saving lives and reducing disability.
  2. The Australian Epilepsy Project, which is providing a platform of artificial intelligence based expertise and clinical decision support. The platform will ensure all epileptics receive best practice care from their first seizure, and will also develop a data base for continuously improving precision medicine.
  3. 4D Functional Diagnosis, a new frontier in lung health for children that will deliver revolutionary lung scanners that are safe, rapid, and easy to use. The scanners will allow functional analysis of lung health and can be immediately applied to managing COVID-19, establishing Australia at the forefront of lung science, and kick-starting a high-value, high-tech industry. 

These projects have the potential to transform outcomes for people living with these diseases and generate massive economic benefits.

The Government has allocated a total of $570 million to the program, over ten years from 2019-20.

ProjectRecipientFunding (GST excl)
The Stroke Golden Hour: delivering urgent stroke care to AustraliansProfessor Geoffrey Donnan and Professor Stephen Davis, University of Melbourne Australian Stroke Alliance$40,167,052
4D Functional Diagnosis: A new frontier in lung health for childrenProfessor Andreas, Fouras Australian Lung Health Initiative            $28,867,540
Australian Epilepsy Project       Professor Graeme Jackson, Florey Institute of Neuroscience and Mental Health$30,080,129
Total $99,114,721

News & Trends - MedTech & Diagnostics

Government commissions review as 70% of private hospitals face financial crisis

Government commissions review as 70% of private hospitals face financial crisis

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: Despite playing a crucial role in providing acute care and surgical services, a staggering 70% of […]

More


News & Trends - Pharmaceuticals

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Health Industry Hub | June 14, 2024 |

Pharma News: The Pharmacy Guild of Australia has echoed the significant concerns of the Australian Competition and Consumer Commission (ACCC) […]

More


News & Trends - MedTech & Diagnostics

Competition watchdog raises concerns over cancer care provider's expansion plans

Competition watchdog raises concerns over cancer care provider’s expansion plans

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: A leading provider of cancer care services in Australia, faces scrutiny from the Australian Competition and […]

More


News & Trends - Biotechnology

Aussie biotech secures first local CAR T patent

Aussie biotech secures first local CAR T patent

Health Industry Hub | June 13, 2024 |

Biotech News: A Melbourne-based biotechnology company which specialises in developing immune cell therapies for cancer treatment, has been granted its […]

More


This content is copyright protected. Please subscribe to gain access.